ResearcherUniversity of PisaActive in the last 2 years
Claudio Ricci
Matched on ORCID iD 0000-0002-0110-8836; OpenAlex author ID A5087883231. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 61
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 8
- Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3↗
- Pancreatic cancer and long survivors: a survey of Italian society of oncological surgery (SICO). Co-author DOI 10.1007/s13304-024-02039-3↗
- Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study. Co-author DOI 10.1245/s10434-022-13054-2↗
- Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre. First author DOI 10.1007/s13304-022-01346-x↗
- Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma. Co-author DOI 10.3748/wjg.v27.i42.7324↗
- 3D Models of Pancreatic Ductal Adenocarcinoma via Tissue Engineering. Co-author DOI 10.1007/978-1-4939-8879-2_8↗
- Uridine Cytidine Kinase 2 as a Potential Biomarker for Treatment with RX-3117 in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13508↗
- Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. Co-author DOI 10.4161/21592527.2014.955386↗
Closest collaborators
The 25 strongest of 61 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Riccardo Casadei · 3 shared papers, 2022–2025 · strength 0.39
- Paper Pancreatic cancer and long survivors: a survey of Italian society of oncological surgery (SICO). DOI 10.1007/s13304-024-02039-3↗
- Paper Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey a… DOI 10.1007/s13304-022-01346-x↗
- Paper Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An Internationa… DOI 10.1245/s10434-022-13054-2↗
- Carlo Ingaldi · 2 shared papers, 2022–2025 · strength 0.28
- Niccola Funel · 3 shared papers, 2014–2021 · strength 0.25
- Paper Uridine Cytidine Kinase 2 as a Potential Biomarker for Treatment with RX-3117 in Pancreatic Cancer. DOI 10.21873/anticanres.13508↗
- Paper Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma. DOI 10.3748/wjg.v27.i42.7324↗
- Paper Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. DOI 10.4161/21592527.2014.955386↗
- Serena Danti · 2 shared papers, 2014–2019 · strength 0.24
- Lapo Bencini · 1 shared paper, 2025 · strength 0.16
- Giovanni Luigi Capretti · 1 shared paper, 2025 · strength 0.16
- Elio Jovine · 1 shared paper, 2025 · strength 0.16
- Riccardo Memeo · 1 shared paper, 2025 · strength 0.16
- Domenico Tamburrino · 1 shared paper, 2025 · strength 0.16
- Gabriella Lionetto · 1 shared paper, 2025 · strength 0.16
- Vincenzo D’Ambra · 1 shared paper, 2025 · strength 0.16
- Silvana B. Puglisi · 1 shared paper, 2025 · strength 0.16
- Roberto Salvia · 1 shared paper, 2025 · strength 0.16
- Ugo Boggi · 2 shared papers, 2014–2023 · strength 0.15
- Paper Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An Internationa… DOI 10.1245/s10434-022-13054-2↗
- Paper Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. DOI 10.4161/21592527.2014.955386↗
- Carla Serra · 1 shared paper, 2022 · strength 0.12
- Deborah Malvi · 1 shared paper, 2022 · strength 0.12
- Mariacristina Di Marco · 1 shared paper, 2022 · strength 0.12
- Francesco Minni · 1 shared paper, 2022 · strength 0.12
- Giovanni Brandi · 1 shared paper, 2022 · strength 0.12
- Tess M. E. van Ramshorst · 1 shared paper, 2023 · strength 0.11
- Patrick Pessaux · 1 shared paper, 2023 · strength 0.11
- Jeffrey W. Chen · 1 shared paper, 2023 · strength 0.11
- Emanuele F. Kauffmann · 1 shared paper, 2023 · strength 0.11
- Tobias Keck · 1 shared paper, 2023 · strength 0.11
- Andrea Pietrabissa · 1 shared paper, 2023 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.